Francyne Kubaski

2.2k total citations
79 papers, 1.5k citations indexed

About

Francyne Kubaski is a scholar working on Physiology, Rheumatology and Epidemiology. According to data from OpenAlex, Francyne Kubaski has authored 79 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Physiology, 21 papers in Rheumatology and 20 papers in Epidemiology. Recurrent topics in Francyne Kubaski's work include Lysosomal Storage Disorders Research (69 papers), Glycogen Storage Diseases and Myoclonus (20 papers) and Trypanosoma species research and implications (15 papers). Francyne Kubaski is often cited by papers focused on Lysosomal Storage Disorders Research (69 papers), Glycogen Storage Diseases and Myoclonus (20 papers) and Trypanosoma species research and implications (15 papers). Francyne Kubaski collaborates with scholars based in United States, Brazil and Japan. Francyne Kubaski's co-authors include Shunji Tomatsu, Robert W. Mason, Tadao Orii, Roberto Giugliani, Yasuyuki Suzuki, Seiji Yamaguchi, Kenji E. Orii, Hironori Kobayashi, Eriko Yasuda and Adriana M. Montaño and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Francyne Kubaski

75 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francyne Kubaski United States 24 1.2k 522 346 307 297 79 1.5k
Calogera M. Simonaro United States 23 1.4k 1.2× 450 0.9× 503 1.5× 251 0.8× 308 1.0× 56 1.9k
Patricia Dickson United States 23 1.1k 1.0× 426 0.8× 415 1.2× 211 0.7× 321 1.1× 109 1.9k
Irène Maire France 21 950 0.8× 387 0.7× 351 1.0× 285 0.9× 358 1.2× 42 1.5k
Nicole Muschol Germany 23 893 0.8× 297 0.6× 291 0.8× 124 0.4× 253 0.9× 93 1.3k
Barbara Czartoryska Poland 21 980 0.8× 496 1.0× 292 0.8× 257 0.8× 299 1.0× 67 1.2k
I Maire France 17 785 0.7× 279 0.5× 341 1.0× 228 0.7× 188 0.6× 85 1.2k
Joan Keutzer United States 29 2.3k 1.9× 673 1.3× 498 1.4× 561 1.8× 598 2.0× 50 2.7k
Juan Politei Argentina 19 1.6k 1.4× 606 1.2× 348 1.0× 405 1.3× 394 1.3× 80 1.9k
Laura Gort Spain 24 758 0.6× 221 0.4× 629 1.8× 275 0.9× 282 0.9× 67 1.3k
Roseline Froissart France 27 2.1k 1.7× 781 1.5× 804 2.3× 494 1.6× 657 2.2× 90 2.8k

Countries citing papers authored by Francyne Kubaski

Since Specialization
Citations

This map shows the geographic impact of Francyne Kubaski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francyne Kubaski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francyne Kubaski more than expected).

Fields of papers citing papers by Francyne Kubaski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francyne Kubaski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francyne Kubaski. The network helps show where Francyne Kubaski may publish in the future.

Co-authorship network of co-authors of Francyne Kubaski

This figure shows the co-authorship network connecting the top 25 collaborators of Francyne Kubaski. A scholar is included among the top collaborators of Francyne Kubaski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francyne Kubaski. Francyne Kubaski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubaski, Francyne, et al.. (2025). Analysis of serum oligosaccharides by UPLC-MS/MS for diagnosis and treatment monitoring of patients with alpha-mannosidosis. Molecular Genetics and Metabolism. 144(3). 109042–109042. 1 indexed citations
2.
Kubaski, Francyne, Laura Pollard, Khaja Basheeruddin, et al.. (2024). High precision newborn screening for mucopolysaccharidosis type I by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysis. Molecular Genetics and Metabolism. 144(2). 108612–108612.
3.
Yu, Seok‐Ho, Francyne Kubaski, Gavin Arno, et al.. (2024). Functional assessment of IDUA variants of uncertain significance identified by newborn screening. npj Genomic Medicine. 9(1). 68–68. 1 indexed citations
4.
Iop, Gabrielle D., Larissa Faqueti, Francyne Kubaski, et al.. (2024). A Brazilian Rare-Disease Center’s Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF. International Journal of Molecular Sciences. 25(5). 2870–2870. 2 indexed citations
5.
Mobini, Moein, Shabnam Radbakhsh, Francyne Kubaski, et al.. (2023). Effects of Trehalose Administration in Patients withMucopolysaccharidosis Type III. Current Medicinal Chemistry. 31(20). 3033–3042. 4 indexed citations
6.
Kubaski, Francyne, Inês Sousa, Camilo Silva, et al.. (2023). Pilot Study of Newborn Screening for Six Lysosomal Diseases in Brazil. SSRN Electronic Journal. 1 indexed citations
7.
Poswar, Fabiano de Oliveira, Wyllians Vendramini Borelli, Gabrielle D. Iop, et al.. (2023). Follow-up of pre-motor symptoms of Parkinson’s disease in adult patients with Gaucher disease type 1 and analysis of their lysosomal enzyme profiles in the CSF. Orphanet Journal of Rare Diseases. 18(1). 309–309. 2 indexed citations
8.
Hong, Xinying, Hsuan-Chieh Liao, Francyne Kubaski, et al.. (2023). Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis. Molecular Genetics and Metabolism. 140(1-2). 107632–107632. 10 indexed citations
9.
Kubaski, Francyne, et al.. (2022). Increased Serum Levels of miR-125b and miR-132 in Fragile X Syndrome. Neurology Genetics. 8(6). e200024–e200024. 2 indexed citations
10.
Kubaski, Francyne, Alberto Burlina, Giulia Polo, et al.. (2022). Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C. International Journal of Neonatal Screening. 8(3). 39–39. 2 indexed citations
11.
Brusius‐Facchin, Ana Carolina, et al.. (2021). Detection of Mosaic Variants in Mothers of MPS II Patients by Next Generation Sequencing. Frontiers in Molecular Biosciences. 8. 789350–789350. 1 indexed citations
12.
Kubaski, Francyne, et al.. (2021). MPSBase: Comprehensive repository of differentially expressed genes for mucopolysaccharidoses. Molecular Genetics and Metabolism. 133(4). 372–377. 3 indexed citations
13.
Kubaski, Francyne, Inês Sousa, Alexandre Wagner Silva de Souza, et al.. (2020). Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives. International Journal of Neonatal Screening. 6(4). 90–90. 9 indexed citations
14.
Stapleton, Molly, Francyne Kubaski, Robert W. Mason, et al.. (2020). Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS. Molecular Genetics and Metabolism Reports. 22. 100563–100563. 28 indexed citations
15.
Stapleton, Molly, et al.. (2018). Clinical presentation and diagnosis of mucopolysaccharidoses. Molecular Genetics and Metabolism. 125(1-2). 4–17. 57 indexed citations
16.
Kubaski, Francyne, Hiromasa Yabe, Yasuyuki Suzuki, et al.. (2017). Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. Biology of Blood and Marrow Transplantation. 23(10). 1795–1803. 80 indexed citations
17.
Kubaski, Francyne, Robert W. Mason, Akiko Nakatomi, et al.. (2016). Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry. Journal of Inherited Metabolic Disease. 40(1). 151–158. 65 indexed citations
18.
Kubaski, Francyne, Yasuyuki Suzuki, Kenji E. Orii, et al.. (2016). Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Molecular Genetics and Metabolism. 120(3). 247–254. 38 indexed citations
19.
Simonaro, Calogera M., Shunji Tomatsu, Tracey Sikora, et al.. (2016). Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs. PLoS ONE. 11(4). e0153136–e0153136. 32 indexed citations
20.
Tomatsu, Shunji, Kazuki Sawamoto, Tsutomu Shimada, et al.. (2015). Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opinion on Orphan Drugs. 3(11). 1279–1290. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Calogera M. Simonaro Breakdown of academic impact, for papers by Patricia Dickson Breakdown of academic impact, for papers by Irène Maire Breakdown of academic impact, for papers by Nicole Muschol Breakdown of academic impact, for papers by Barbara Czartoryska Breakdown of academic impact, for papers by I Maire Breakdown of academic impact, for papers by Joan Keutzer Breakdown of academic impact, for papers by Juan Politei Breakdown of academic impact, for papers by Laura Gort Breakdown of academic impact, for papers by Roseline Froissart
Rankless by CCL
2026